Global Drug
Safety Services

PrimeVigilance, an Ergomed Group company,
employs over 500 highly qualified
professionals and offers competitive,
right-shoring solutions around the globe.

About us

Drug Safety

We have a proven track record in Pharmacovigilance,
managing Medical Information queries and now
bring our partners Pharmacoepidemology & Risk
Management solutions.

About us

Today’s Needs

Our expertise and commercial vision
means you can rely on us to deliver high quality,
compliant and cost-effective solutions

Contact us

A Global Leader in
QPPV Services

PrimeVigilance have become WORLDWIDE NUMBER ONE
in QPPV services with 25 EU QPPV assignments, as well as
25 Deputy EU QPPVs, and our local QPPV/NPRP network
covering over 60 countries.

Find out more

    Clinical trial safety and postmarketing

    Dedicated to providing Pharmacovigilance services for over 10 years, we cover the entire product life cycle to better assist clients with the effective management of their drug safety information.



    Pharmacoepidemiology and risk management solutions

    Offering optimal approaches to lifecycle benefit-risk management by providing systematic risk minimisation and faster insights into the safety and effectiveness of drugs to ensure patient safety and to meet evolving regulatory demands.



    Healthcare professional and customer queries

    PrimeVigilance is a quality resource for concise, timely and accurate communication with highly trained, industry experienced healthcare professionals providing medical information.


    EVDAS-related expectations from MAHs UPDATE on the discussions taking place during pilot phase

    EVDAS outputs – Part 2

    Featured Speaker:

    Watch now

    What is Pharmacovigilance?

    In partnership with our clients, PrimeVigilance is committed to improving patient health.



    Join the PrimeVigilance team

    Our success begins with our people. Build your career in one of the most rewarding fields in the world.


    News – Dr. Michael Forstner & Dr. Jan Petracek selected to speak at DIA Pharmacovigilance & Risk Management Strategies Conference


    News – Ergomed shortlisted for Best Technological Development in Clinical Trials at SCRIP Awards 2018


    NEWS – PrimeVigilance becomes a global leader in QPPV services